Where does Mallinckrodt Hospital Products IP Unlimited Company rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Mallinckrodt Hospital Products IP Unlimited Company ranks #4,250 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

What is Mallinckrodt Hospital Products IP Unlimited Company's Innovation Score?

Mallinckrodt Hospital Products IP Unlimited Company has an Innovation Score of 45.0 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Mallinckrodt Hospital Products IP Unlimited Company's patent grant rate increasing or decreasing?

Mallinckrodt Hospital Products IP Unlimited Company's recent grant velocity is -27% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Mallinckrodt Hospital Products IP Unlimited Company's patents?

Mallinckrodt Hospital Products IP Unlimited Company's patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Mallinckrodt Hospital Products IP Unlimited Company

Q: How many patents does Mallinckrodt Hospital Products IP Unlimited Company hold?

Mallinckrodt Hospital Products IP Unlimited Company holds 84 US utility patents granted between 2016 and 2025, spanning 29 technology areas.

Q: What technology areas does Mallinckrodt Hospital Products IP Unlimited Company focus on?

Mallinckrodt Hospital Products IP Unlimited Company's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 67 patents, ranking #111 of 3,490 assignees active in that subclass. Grants appear in 29 CPC subclasses total.

Q: How is the Mallinckrodt Hospital Products IP Unlimited Company patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 84 granted patents across 29 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mallinckrodt ranks #4,250 of 49,997 tracked US assignees by granted-patent volume, with 84 patents across 29 technology areas.

#4,250
of 49,997 US assignees by volume: Top 24%
by Innovation Score (45.0/100): 16.6
avg claims per patent: -27%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4250 · Foreign Corporation #4,250 · 84 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 84 grants
TOP-DECILE #4,250/49,997
PHOTO-FINISH Inovio Pharmaceuticals
CPC-FOCUS A61M · 29 areas
INNOV-PAR 45.0/100
CLAIMS-RICH 16.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -27% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Inovio Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Mallinckrodt’s 45.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.3 pts (34%) Velocity 0.6 pts (1%) Breadth 19.0 pts (42%) Claim depth 10.0 pts (22%)

Qualcomm Incorporated · highest

85
Fujifilm Toyama… · near

45
Grass Valley · near

45
Mallinckrodt… · this assignee

45
Timotion Technology · near

45
Weinberg Medical… · near

45
3D Lighting… · lowest

7

What this shows Mallinckrodt's Innovation Score is 45.0/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Mallinckrodt?

Each dot is one of Mallinckrodt’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mallinckrodt’s own 16.6 claims/patent is ABOVE the 13.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Mallinckrodt vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Mallinckrodt's grants concentrate

Mallinckrodt Hospital Products IP Unlimited Company is a focused PatentsView assignee: 29 CPC subclasses with 79.8% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (22 grants) versus a trough of 1 in 2022. By volume, Mallinckrodt sits between Inovio Pharmaceuticals, Inc. and Orthosensor Inc..

Mallinckrodt's three-year grant acceleration

From 2019–2021 to 2022–2024, Mallinckrodt Hospital Products IP Unlimited Company moved from 52 to 5 grants (0.10x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Inovio Pharmaceut…

84
Jtekt Europe

84
Kitagawa Industri…

84
M Technique

84
National Health R…

84
Nisca

84
Optis Cellular Te…

84
Orthosensor

84
Mallinckrodt Hosp… ◀

84

What this shows Mallinckrodt holds 84 patents at rank #4,250, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mallinckrodt

By rank, the assignees closest to #4,250 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Mallinckrodt's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Mallinckrodt, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Mallinckrodt ranks #111 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Timotion Technology Co., Ltd. 45 Fujifilm Toyama Chemical Co., Ltd. 45 Weinberg Medical Physics, Inc 45 Grass Valley Limited 45

Similar claim depth

Nearest assignees by average claims per patent (16.6 here).

Coherent, Inc. 16.6 avg Alpha and Omega Semiconductor (Cayman) Ltd. 16.6 avg Flexterra, Inc. 16.6 avg Medtronic Vascular Galway Unlimited Company 16.6 avg

Mallinckrodt's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Mallinckrodt Hospital Products IP Unlimited Company patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	6	7.1%
2017	10	11.9%
2018	10	11.9%
2019	22	26.2%
2020	18	21.4%
2021	12	14.3%
2022	1	1.2%
2023	2	2.4%
2024	2	2.4%
2025partial year	1	1.2%

Which technologies does Mallinckrodt Hospital Products IP Unlimited Company patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 67

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 20

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 17

F17C - Vessels FOR Containing OR Storing Compressed, Liquefied OR Solidified GASES; Fixed-capacity GAS-HOLDERS; Filling Vessels With, OR Discharging From Vessels, Compressed, Liquefied, OR Solidified Gases 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

Y02A - Technologies FOR Adaptation TO Climate Change 9

B04B - Centrifuges 8

A61B - DIAGNOSIS; SURGERY; Identification 8

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 6

B01D - Separation 6

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 6

B63C - Launching, Hauling-out, OR Dry-docking OF VESSELS; Life-saving IN WATER; Equipment FOR Dwelling OR Working Under WATER; Means FOR Salvaging OR Searching FOR Underwater Objects 4

C01B - Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c 4

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 3

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 3

Top 15 of 29 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Mallinckrodt Hospital Products IP Unlimited Company's patent record in context - here's where to go next.

Mallinckrodt Hospital Products IP Unlimited Company's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 79.8% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #4,250 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Mallinckrodt Hospital Products IP Unlimited Company against Inovio Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.